An anti-vaccine organization founded by HHS Secretary Robert F. Kennedy Jr. is urging the FDA he now oversees to pull the ...
A new Tufts study found that Medicare price negotiations on biologics with imminent biosimilars could lead to near-term savings, but greater savings are likely from biosimilar competition.
Company receives the highest Water Security rating in two years into participationRecognized for exceptional leadership in ...
Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...
With the help of artificial intelligence, an international team of researchers has made the first major inroad to date toward ...
In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes' ...
Launching December 9, Biologica is a set of new supplements for women’s health, naturally flavored and powdered to fizz into water. Each single sachet, or separately sealed daily dose to be mixed with ...
In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...
The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...
The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...
Remicade, the brand name for infliximab, is an intravenous biologic therapy for conditions such as Crohn's disease, ...
A vaccine advisory panel on Friday voted to end its recommendation that kids receive hepatitis B vaccine at birth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback